ABVX FINANCIAL STATEMENTS

Abivax SA American Depositary Shares — balance sheet, income statement and cash flow trends

ABVXAbivax SA American Depositary Shares

🇺🇸 USA · US · Healthcare · Biotechnology

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Key Figures

YoY change

Revenue——

Gross Profit——

Operating Income——

EBITDA——

Net Income——

Peer Comparison· Biotechnology

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
ABVX	—	—	—	—
Industry median	4.1%	84.0%	-105.8%	-125.7%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity429.6 M €79%
Current Liabilities62.2 M €11%
Long-term Liabilities55.3 M €10%

Key Figures

YoY change

Total Assets547.1 M €+67.3%

Total Liabilities117.5 M €-10.3%

Total Equity429.6 M €+119.2%

Cash & ST Investments——

Total Debt——

Net Debt——

Peer Comparison· Biotechnology

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
ABVX	8.25	—	—	78.5%
Industry median	5.90	10.9%	1.15	70.0%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow——

Capital Expenditures——

Free Cash Flow——

Dividends Paid——

Peer Comparison· Biotechnology

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
ABVX	—	—	—	—
Industry median	-88.0%	-90.9%	1.9%	81.5%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ABVX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. This content is for informational purposes only and is not investment advice.